Related Experiment Video
Updated: May 23, 2026
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Transfusion delay after hemoglobin trigger and in-hospital outcomes in patients with nonvariceal upper
Xuhui Lian1, Xu Zhang1, Xianfang He1
1Department of Blood Transfusion, Dazhu County People's Hospital, Dazhou 635100, China.
Background:
Red blood cell transfusion is an important component of supportive care in selected patients with nonvariceal upper gastrointestinal bleeding (NVUGIB). Although current guidelines emphasize restrictive transfusion thresholds, the clinical impact of transfusion delay after the hemoglobin trigger is less clear. This study examined whether delayed transfusion after a hemoglobin value≤7.0g/dL was associated with adverse in-hospital outcomes in patients with NVUGIB.
Methods:
We conducted a retrospective cohort study of adult patients hospitalized with NVUGIB who reached a hemoglobin trigger of≤7.0g/dL. The trigger time was defined as the index time. A 3-hour landmark design was used to classify patients into early transfusion, defined as red blood cell transfusion initiated within 3hours after the trigger, and delayed transfusion, defined as no transfusion by the 3-hour landmark. The primary outcome was a composite adverse in-hospital outcome, including in-hospital mortality, rebleeding, or intensive care unit admission. Multivariable regression models were used to estimate associations between transfusion timing and outcomes.
Results:
A total of 859 patients were included, including 458 in the early transfusion group and 401 in the delayed transfusion group. Delayed transfusion was associated with higher rates of rebleeding, intensive care unit admission, composite adverse outcome, and longer hospital stay. After full adjustment, delayed transfusion remained associated with increased odds of the composite outcome (OR 2.49, 95% CI 1.82-3.39), in-hospital mortality (OR 2.38, 95% CI 1.41-4.02), rebleeding (OR 1.56, 95% CI 1.05-2.31), and intensive care unit admission (OR 3.34, 95% CI 2.31-4.84). Delayed transfusion was also associated with longer length of stay.
Conclusion:
Among patients with NVUGIB who reached a hemoglobin threshold of≤7.0g/dL, delayed transfusion was associated with worse in-hospital outcomes. These findings suggest that timely transfusion after reaching the hemoglobin trigger may be clinically important.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:24Esophageal Varices-I: Introduction
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...